Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear Cell, Metastatic Renal Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT01977586
What this trial is testing

Functional Imaging in the Assessment of mRCC Response to Sunitinib

Who this might be right for
Metastatic Renal Cell Carcinoma
Imperial College Healthcare NHS Trust
Early research (Phase 1)Study completedNCT02315066
What this trial is testing

Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566

Who this might be right for
Neoplasms
Pfizer 174
Testing effectiveness (Phase 2)Study completedNCT02700568
What this trial is testing

Axitinib in Metastatic Renal Cell Carcinoma Patients With Favorable Prognostic Factors

Who this might be right for
Carcinoma, Renal CellClear Cell Renal Cell Carcinoma
Kidney Cancer Research Bureau 21
Not applicableWithdrawnNCT00499291
What this trial is testing

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors

Who this might be right for
Cancer
Eastern Cooperative Oncology Group
Early research (Phase 1)Ended earlyNCT02595918
What this trial is testing

Nivolumab in Treating Patients With High-Risk Kidney Cancer Before Surgery

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Renal Cell CarcinomaStage I Renal Cell Cancer AJCC v6 and v7+3 more
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT05012371
What this trial is testing

Lenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+1 more
M.D. Anderson Cancer Center 90
Testing effectiveness (Phase 2)Ended earlyNCT01582009
What this trial is testing

Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage III Renal Cell Cancer+1 more
Roswell Park Cancer Institute 26
Testing effectiveness (Phase 2)Study completedNCT01499121
What this trial is testing

Study of Efficacy and Safety of Sunitinib Given on an Individualized Schedule

Who this might be right for
Clear Cell, Metastatic Renal Cell Carcinoma
Sunnybrook Health Sciences Centre 117
Early research (Phase 1)Looking for participantsNCT07062549
What this trial is testing

Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal Cell

Who this might be right for
Renal Cell Carcinoma (Kidney Cancer)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 6
Testing effectiveness (Phase 2)Study completedNCT02348008
What this trial is testing

Phase Ib and Phase II Studies of MK-3475 in Combination + for Renal Cell Carcinoma:

Who this might be right for
Clear Cell Renal Carcinoma
Arkadiusz Z. Dudek, MD 61
Testing effectiveness (Phase 2)UnknownNCT04995016
What this trial is testing

Pembrolizumab and Axitinib as Neoadjuvant Therapy for Locally Advanced Non-metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaClear Cell Renal Cell Carcinoma
Tianjin Medical University Second Hospital 18
Testing effectiveness (Phase 2)UnknownNCT03177239
What this trial is testing

Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Metastatic or Unresectable Non-Clear Cell Renal Cell Carcinoma (ANZUP1602)

Who this might be right for
Renal Cell CarcinomaPapillary Renal Cell Carcinoma Type 1Papillary Renal Cell Carcinoma Type 2+3 more
Australian and New Zealand Urogenital and Prostate Cancer Trials Group 85
Testing effectiveness (Phase 2)Study completedNCT00853021
What this trial is testing

Bevacizumab and Aldesleukin in Treating Patients With Metastatic Clear Cell Carcinoma of the Kidney

Who this might be right for
Kidney Cancer
Jorge A. Garcia, MD 26
Testing effectiveness (Phase 2)Study completedNCT00003657
What this trial is testing

High-dose ICE With Amifostine

Who this might be right for
Bladder CancerBrain and Central Nervous System TumorsCarcinoma of Unknown Primary+8 more
Dana-Farber Cancer Institute 24
Testing effectiveness (Phase 2)Looking for participantsNCT07510334
What this trial is testing

VSV-IFNβ-NIS With Ipilimumab and Nivolumab for the Treatment of Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+1 more
Mayo Clinic 18
Testing effectiveness (Phase 2)UnknownNCT03987698
What this trial is testing

Study of PD-1 Inhibitor Combination With Autologous Cell Immunotherapy in the Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaClear Cell Renal Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT03635892
What this trial is testing

Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma

Who this might be right for
Advanced or Metastatic Non-clear Cell Renal Cell CarcinomaUnclassified Renal Cell CarcinomaPapillary Renal Cell Carcinoma+4 more
Memorial Sloan Kettering Cancer Center 60
Very early researchUnknownNCT06428708
What this trial is testing

[18F] PSMA-1007 PET/CT in Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
Western University 30
Not applicableStudy completedNCT07354282
What this trial is testing

Real World Evidence of Tivozanib as First-line Treatment for Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Renal Cell Cancer Metastatic
Spanish Oncology Genito-Urinary Group 200
Post-approval studies (Phase 4)Looking for participantsNCT07028125
What this trial is testing

Digital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal Carcinoma

Who this might be right for
Renal Cell Carcinoma (Kidney Cancer)Metastatic Renal Cell CarcinomaLocally Advanced
Centre Francois Baclesse 83
Next Page